Frailty index to measure health status in people with systemic sclerosis

Journal of Rheumatology

Volumn 41, Issue 4, 2014, Pages 698-705

  Rockwood, Michael R ^a   MacDonald, Ellen ^a   Sutton, Evelyn ^b   Rockwood, Kenneth ^a   Baron, Murray ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Frailty; Frailty index; Scleroderma; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE REGISTRY; FEASIBILITY STUDY; FEMALE; FRAILTY INDEX; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL PARAMETERS; MORTALITY; PHYSICIAN ASSESSMENT OF DAMAGE; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RODNAN SKIN SCORE; SCORING SYSTEM; SYSTEMIC SCLEROSIS; TREATMENT INDICATION; VALIDATION PROCESS; AGE; AGED; CANADA; CAUSE OF DEATH; DISEASE COURSE; FACTUAL DATABASE; FRAIL ELDERLY; HEALTH STATUS INDICATOR; MIDDLE AGED; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REGISTER; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VALIDATION STUDY;

ADULT; AGE FACTORS; AGED; CAUSE OF DEATH; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; FRAIL ELDERLY; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; NOVA SCOTIA; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; REGISTRIES; RISK ASSESSMENT; ROC CURVE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL RATE;

EID: 84897449143     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130182     Document Type: Article

References (47)

1. Nikpour M, Stevens W, Herrick A, Proudman S. Epidemiology of systemic sclerosis. Best Pract Res Clin Rheumatol 2010;24:857-69.
2. Kirkwood TB. Systems biology of ageing and longevity. Philos Trans R Soc Lond B Biol Sci 2011;366:64-70.
3. Fulop T, Larbi A, Witkowski JM, McElhaney J, Loeb M, Mitnitski A, et al. Aging, frailty and age-related diseases. Biogerontology 2010;11:547-63.
4. Partridge JS, Harari D, Dhesi JK. Frailty in the older surgical patient: a review. Age Ageing 2012;41:142-7.
5. Sternberg SA, Wershof Schwartz A, Karunananthan S, Bergman H, Mark Clarfield A. The identification of frailty: a systematic literature review. J Am Geriatr Soc 2011;59:2129-38.
6. de Vries NM, Staal JB, van Ravensberg CD, Hobbelen JS, Olde Rikkert MG, Nijhuis-van der Sanden MW. Outcome instruments to measure frailty: a systematic review. Ageing Res Rev 2011; 10:104-14.
7. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med 2001;56:M146-56.
8. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal 2001;1:323-36.
9. Seibold Jr. Scleroderma. In: Harris ED Jr, Budd RC, Firestein GS, Genovese MC, Sargent JS, Ruddy S, et al, editors. Kelley's textbook of rheumatology, 7th ed. Philadelphia: Elsevier Saunders; 2005:1279-308.
10. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 2002;81:139-53.
11. Valentini G. The assessment of the patient with systemic sclerosis. Autoimmun Rev 2003;2:370-6.
12. Hudson M, Steele R, Canadian Scleroderma Research Group (CSRG), Baron M. Update on indices of disease activity in systemic sclerosis. Semin Arthritis Rheum 2007;37:93-8.
13. Caron M, Hudson M, Baron M, Nessim S, Steele R; Canadian Scleroderma Research Group. Longitudinal study of renal function in systemic sclerosis. J Rheumatol 2012;39:1829-34.
14. Galluccio F, Walker UA, Nihtyanova S, Moinzadeh P, Hunzelmann N, Krieg T, et al. Registries in systemic sclerosis: a worldwide experience. Rheumatology 2011;50:60-8.
15. Elhai M, Meune C, Avouac J, Kahan A, Allanore Y. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology 2012;51:1017-26.
16. Hudson M, Mahler M, Pope J, You D, Tatibouet S, Steele R, et al Investigators of the Canadian Scleroderma Research Group. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis. J Rheumatol 2012;39:787-94.
17. Canadian Scleroderma Research Group. CSRG registry. [Internet. Accessed January 22, 2013.] Available from http://canadian-scleroderma-research-group.ca
18. Searle S, Mitnitski A, Gahbauer E, Gill T, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr 2008;8:24.
19. Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 2011;27:17-26.
20. Kroenke K, Spitzer R, Williams J. The PHQ-0: Validity of a Brief Depression Severity Index. J Gen Intern Med 2001;16:606-13.
21. FACIT fatigue scale. [page on the Internet]. Last accessed January 7, 2013. Available from http://www.facit.org/FACITOrg/Questionnaires
22. PROMIS. PROMIS sleep scale. [Internet. Accessed January 7, 2013.] Available from https://www.assessmentcenter.net/PromisForms.aspx
23. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 4th ed. USA: Oxford University Press, 2008.
24. Mitnitski A, Song X, Skoog I, Broe GA, Cox JL, Grunfeld E, et al. Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J Am Geriatr Soc 2005;53:2184-9.
25. Rockwood K, Mitnitski A. Limits to deficit accumulation in elderly people. Mech Ageing Dev 2006;127:494-6.
26. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6.
27. Symmons DP. Disease assessment indices: activity, damage and severity. Baillieres Clin Rheumatol 1995;9:267-85.
28. Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, et al Scleroderma Clinical Trials Consortium. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum 2002;46:2410-20.
29. Collerton J, Martin-Ruiz C, Davies K, Hilkens CM, Isaacs J, Kolenda C, et al. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev 2012;133:456-66.
30. Li H, Manwani B, Leng SX. Frailty, inflammation, and immunity. Aging Dis 2011;2:466-73.
31. Cenit MC, Simeon CP, Vonk MC, Callejas-Rubio JL, Espinosa G, Carreira P, et al. Influence of the IL6 gene in susceptibility to systemic sclerosis. J Rheumatol 2012;39:2294-302.
32. Muangchan C, Pope JE. Interleukin 6 in systemic sclerosis and potential implications for targeted therapy. J Rheumatol 2012;39:1120-4.
33. Ridda I, Macintyre C, Lindley R, Gao Z, Sullivan J, Yuan F, et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 2009;27:1628-36.
34. Hashimoto A, Tejima S, Tono T, Suzuki M, Tanaka S, Matsui T, et al. Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 2011;38:1931-9.
35. Clements PL, Lachenbruch RA, Ng SC, Simmons M, Sterz M, Furst DE. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1990;33:1256-63.
36. Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 1998;37:750-5.
37. Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001;44:2828-35.
38. Kulminski AM, Arbeev KG, Christensen K, Mayeux R, Newman AB, Province MA, et al. Do gender, disability, and morbidity affect aging rate in the LLFS? Application of indices of cumulative deficits. Mech Ageing Dev 2011;132:195-201.
39. Rockwood K, Song X, Mitnitski A. Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey. CMAJ 2011;183:E487-94.
40. Schoufour JD, Mitnitski A, Rockwood K, Evenhuis HM, Echteld MA. Development of a frailty index for older people with intellectual disabilities: Results from the HA-ID study. Res Dev Disabil 2013;34:1541-55.
41. Juby A, Davis P. An evaluation of the impact of seniors on a rheumatology referral clinic: demographics and pharmacotherapy. Clin Rheumatol 2011;30:1507-9.
42. Kulminski A, Yashin A, Ukraintseva S, Akushevich I, Arbeev K, Land K, et al. Accumulation of health disorders as a systemic measure of aging: Findings from the NLTCS data. Mech Ageing Dev 2006;127:840-8.
43. Bennett S, Song X, Mitnitski A, Rockwood K. A limit to frailty in very old, community-dwelling people: a secondary analysis of the Chinese longitudinal health and longevity study. Age Ageing 2013;42:372-7.
44. Kulminski AM, Arbeev KG, Ukraintseva SV, Culminskaya IV, Land K, Yashin AI. Changes in health status among participants of the Framingham Heart Study from the 1960s to the 1990s: application of an index of cumulative deficits. Ann Epidemiol 2008;18:696-701.
45. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013;381:752-62.
46. Song X, Mitnitski A, Rockwood K. Nontraditional risk factors combine to predict Alzheimer disease and dementia. Neurology 2011;77:227-34.
47. Dartigues JF, Feart C. Risk factors for Alzheimer disease: aging beyond age? Neurology 2011;77:206-7.